e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Monitoring and phenotyping COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Expression of matrix metalloproteinases in bronchoalveolar cells in COPD and in COPD phenotypes
Jaromir Zatloukal (Olomouc, Czech Republic), Jaromir Zatloukal, Zdenka Navratilova, Eva Kriegova, Vladimir Koblizek, Vitezslav Kolek, Martin Petrek
Source:
International Congress 2015 – Monitoring and phenotyping COPD
Session:
Monitoring and phenotyping COPD
Session type:
Oral Presentation
Number:
2919
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jaromir Zatloukal (Olomouc, Czech Republic), Jaromir Zatloukal, Zdenka Navratilova, Eva Kriegova, Vladimir Koblizek, Vitezslav Kolek, Martin Petrek. Expression of matrix metalloproteinases in bronchoalveolar cells in COPD and in COPD phenotypes. Eur Respir J 2015; 46: Suppl. 59, 2919
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Glycosaminoglycans significantly correlate with matrix metalloproteinases during exacerbations of COPD
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
The use of bronchoalveolar lavage (BAL) to assess lower airways inflammation in asthma
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Bronchoalveolar lavage tryptase levels are correlated with type 2 airway inflammation in mild asthma
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Level of cytokines in bronchoalveolar lavage fluid (BALF) in patients with professional lung diseases and COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 67s
Year: 2001
Bronchoalveolar lavage in COPD, smokers and non-smokers: inflammatory cells and macrophage phenotype
Source: Annual Congress 2004 - Acute exacerbations and drug therapy in COPD
Year: 2004
Overexpression of matrix metalloproteinase-7 (MMP-7) in bronchoalveolar lavage fluid (BALF) of IPF and lung cancer patients
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011
Periostin in lower airway samples and serum, a novel asthma marker?
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Characteristics of endobronchial dendritic cells in patients with stable COPD
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases?
Source: International Congress 2015 – New insights into IIPs
Year: 2015
The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Bronchoalveolar lavage: how can we use it more effectively to define pathology?
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006
Studies on hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) do not support the concept on its antifibrotic properties in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Investigation of mitochondria homeostasis and mitophagy in bronchoalveolar lavage fluid (BALF) cells in pulmonary fibrosis
Source: International Congress 2015 – IPF pathogenesis
Year: 2015
Levels of antimicrobial peptide LL-37 in BALF and ELF from patients with pulmonary fibrosis
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Exosomes are differentially present in bronchoalveolar lavage (BAL) of smokers and patients with COPD and IPF
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019
Matrix metalloproteinase-9 (MMP-9) elevated in serum, but not in bronchial lavage in lung cancer patients
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Sputum rather than bronchoalveolar lavage (BAL) cells are associated with small airways function in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 198s
Year: 2002
Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005
Determinants of oxidants load in broncho-alveiolar milieu
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept